Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Neervalur V Raghavan


Neervalur V Raghavan

RAGS PHARMA CONSULTING, LLC. USA

Biography

Dr. Neervalur Raghavan is an experienced leader of R&D organizations that have successfully developed novel formulations and implemented practical manufacturing solutions for drug entities that have poor solubility and limited shelflife. Provided key leadership to drive strategic business initiatives, longterm process optimization activities and the technical development of a scientific staff that is known throughout the industry. Responsible for developing over 200 product presentations that include novel frozen drug formulations, inhalation therapy products, sterile, readytouse injectable antibiotic solutions and aseptic formfillseal injectable products. Organizations under leadership were responsible for more than 150 patents and innovations for products that continue to save millions of lives each year and generate an annual GP of over $100 million (parental products) or related business that drives strategic initiatives, including new product development, longterm process/optimization activities, quality assurance, while ensuring all objectives are met and meet product safety and quality requirements. He has earned a Ph.D degree in chemistry from University of Southern California, Los Angeles. After serving as a postdoctoral fellow at Ohio State University, he joined University of Notre Dame focusing on radiation chemistry of low levels of aromatic aqueous solutions , utilizing HPLC and fast reaction kinetics. Then he joined Baxter Health Care Corporation and served there over thirty years , with increased responsibility, on sterile drug product development . He retired as VP of Pharmaceutical Product Development R&D. He had active membership with AAPS and ACS

Abstract

Abstract : Systematic approach to development of aqueous drug formulation and drug device combination injectable products and challenges